Regeneron Pharmaceuticals Inc at Barclays Biopharmaceuticals CEO/CFO Conference Call Series Transcript
Good morning. My name is Latania, and I will be your conference operator today. At this time, I would like to welcome everyone to the Barclays Biopharma CEO/CFO Conference Call Series with Regeneron. (Operator Instructions)
I would now like to turn the call over to your host, Mr. Geoff Meacham. Sir, you may begin.
Okay. Great. Thanks, Latania, and thanks, everyone, for joining us. I'm Geoff Meacham. I'm the senior biopharma analyst here at Barclays. My team is on the phone as well. We have Greg, Scott, [Olivia] and Jason, and we're thrilled to have Regeneron as part of our CEO/CFO call series. And we have a big crew today. We have Marion McCourt who's Senior Vice President, Head of Commercial. We have Bob Landry who's Executive Vice President and CFO. And then we have Jay Markowitz as well who is Senior Vice President, Portfolio Management. So welcome, guys.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |